The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Rating of “Moderate Buy” by Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has earned an average rating of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $117.22.

A number of analysts have recently commented on COO shares. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Wells Fargo & Company increased their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th.

Hedge Funds Weigh In On Cooper Companies

Hedge funds have recently made changes to their positions in the business. Ashton Thomas Securities LLC acquired a new stake in shares of Cooper Companies in the 3rd quarter valued at approximately $25,000. Covestor Ltd boosted its holdings in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the last quarter. Byrne Asset Management LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $34,000. Finally, New Age Alpha Advisors LLC acquired a new stake in Cooper Companies during the 4th quarter valued at $38,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

Shares of COO stock opened at $90.67 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock has a market cap of $18.10 billion, a PE ratio of 46.50, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The stock has a 50-day moving average of $92.58 and a 200-day moving average of $99.57. Cooper Companies has a one year low of $84.76 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.87 EPS. As a group, sell-side analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.